You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Cyproterone acetate, ethinyl estradiol drug combination

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Females With PCOS on CPA/EE Combination Drug Regimen

Not yet recruiting
  • Periodontitis
  • +2 more
  • Cyproterone Acetate, Ethinyl Estradiol Drug Combination
  • +2 more
  • Rohtak, Haryana, India
    Post Graduate Institute of Dental Science
Nov 11, 2021

"Effect of CPA/EE Drug on Periodontal Tissue and hsCRP Levels in

Not yet recruiting
  • Periodontal Diseases
  • cyproterone Acetate/Ethinyl Estradiol Combination
  • Rohtak, Haryana, India
    Post Graduate Institute of Dental Sciences
Dec 10, 2022

Drug Use Trial in Multiple Locations (Elzsa film-coated tablet, Diane-35 Sugar-coated tablet)

Completed
Has Results
  • Drug Use
  • Elzsa film-coated tablet
  • Diane-35 Sugar-coated tablet
  • Multiple Locations, Jakarta, Indonesia
    PT Pharma Metric Labs
Jan 28, 2022

CPA/EE in 5 European Countries

Completed
Has Results
  • Hirsutism
  • +4 more
    • Berlin, Germany
      Center of Epidemiology and Health Research
    Aug 26, 2021

    Polycystic Ovary Syndrome Trial in Malatya (Yasmin, Diane-35)

    Recruiting
    • Polycystic Ovary Syndrome
    • Malatya, Turkey
      Inonu University
    May 18, 2022

    HCV Infection Trial in Christchurch (SOF/VEL/VOX, VOX, Norgestimate/ethinyl estradiol)

    Completed
    Has Results
    • HCV Infection
    • Christchurch, New Zealand
      (unnamed)
    Aug 17, 2020

    Solid Tumors Trial in Worldwide (Trametinib, Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol))

    Completed
    • Solid Tumors
    • Trametinib
    • Oral Contraceptive (1mg norethindrone, 0.035mg ethinyl estradiol)
    • Detroit, Michigan
    • +6 more
    Feb 7, 2022

    Healthy Female Participants Trial in Brooklyn (Zibotentan, EE/LNG)

    Not yet recruiting
    • Healthy Female Participants
    • Brooklyn, Maryland
      Research Site
    Aug 16, 2022

    PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, Depression, Anxiety Trial in Shanghai (Oral Contraceptives, Combined,

    Recruiting
    • PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries
    • Depression, Anxiety
    • Oral Contraceptives, Combined
    • +2 more
    • Shanghai, Shanghai, China
      OB & GYN Hospital of Fudan University
    Jul 24, 2021

    Relapsing Multiple Sclerosis (RMS) Trial in Germany, Poland (Cladribine, Placebo, Microgynon®)

    Active, not recruiting
    • Relapsing Multiple Sclerosis (RMS)
    • Bochum, Germany
    • +6 more
    Feb 8, 2022

    Therapeutic Equivalency Trial in Chennai (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Microgynon CD)

    Completed
    • Therapeutic Equivalency
    • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
    • Microgynon CD
    • Chennai, Tamil Nadu, India
      Azidus Laboratories Ltd.
    May 31, 2022

    MYFEMBREE®: A Retrospective Cohort Study UsingAdministrative

    Not yet recruiting
    • Pregnancy Related
    • +2 more
    • Relugolix + Estradiol + Norethindrone Acetate
    • (no location specified)
    Feb 13, 2023

    Menopausal Symptoms Trial in Stockholm (Micronized progesterone in continuous combination with oral estrogen, Norethisterone

    Recruiting
    • Menopausal Symptoms
    • Micronized progesterone in continuous combination with oral estrogen
    • Norethisterone acetate in continuous combination with oral estrogen
    • Stockholm, Sweden
      Karolinska University Hospital
    Oct 21, 2022

    Contraception Trial (Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets, norelgestrominum and

    Completed
    Has Results
    • Contraception
    • Levonorgestrel (LNG)/Ethinylestradiol (EE) oral contraceptive tablets
    • +2 more
    • (no location specified)
    Feb 2, 2022

    Heavy Menstrual Bleeding, Uterine Fibroids Trial in Puerto Rico, United States (Elagolix Placebo, E2/NETA, E2/NETA Placebo)

    Active, not recruiting
    • Heavy Menstrual Bleeding
    • Uterine Fibroids
    • Elagolix Placebo
    • +3 more
    • Birmingham, Alabama
    • +156 more
    Jan 20, 2022

    Healthy Participants Trial (BMS-986322, Loestrin)

    Not yet recruiting
    • Healthy Participants
    • (no location specified)
    Oct 11, 2022

    Contraception Trial (NOMAC-E2, DRSP-EE)

    Completed
    Has Results
    • Contraception
    • (no location specified)
    Feb 7, 2022

    Uterine Fibroids, Heavy Menstrual Bleeding Trial in Canada, United States (Elagolix, Placebo for Estradiol/Norethindrone

    Completed
    Has Results
    • Uterine Fibroids
    • Heavy Menstrual Bleeding
    • Birmingham, Alabama
    • +104 more
    Jul 9, 2021

    Contraception Trial (NOMAC-E2, DRSP-EE)

    Completed
    Has Results
    • Contraception
    • (no location specified)
    Feb 7, 2022

    Contraception Trial (NOMAC-E2, DRSP-EE)

    Completed
    Has Results
    • Contraception
    • (no location specified)
    Feb 7, 2022

    Pelvic Pain Trial in Hangzhou (Aspirin, Drospirenone ethinyl estradiol)

    Recruiting
    • Pelvic Pain
    • Aspirin
    • Drospirenone ethinyl estradiol
    • Hangzhou, Zhejiang, China
      Women's Hospital School of Medicine Zhejiang University
    Jan 20, 2022

    Bioequivalence Trial in Santiago (Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug, Levonorgestrel 15.0 mg and

    Completed
    • Bioequivalence
    • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Test Drug
    • Levonorgestrel 15.0 mg and Ethinyl estradiol 0.03 mg Reference Product
    • Santiago, Chile
      Innolab
    Feb 8, 2021

    Hiv, Transgenderism Trial in Toronto (Biktarvy 50/200/25 Tab, Estradiol Tablets)

    Recruiting
    • Hiv
    • Transgenderism
    • Biktarvy 50/200/25 Tab
    • Estradiol Tablets
    • Toronto, Ontario, Canada
      Maple Leaf Research
    Dec 15, 2022

    Healthy Trial in Merksem (JNJ-55308942 High Dose, JNJ-55308942 Low Dose, Levonorgestrel/Ethinyl Estradiol Fixed Dose combination

    Completed
    • Healthy
    • JNJ-55308942 High Dose
    • +3 more
    • Merksem, Belgium
      Clinical Pharmacology Unit
    Sep 27, 2018

    Healthy Postmenopausal Females Trial (Commercial NOMAC-E2, Phase 3 NOMAC-E2 "Batch A", Phase 3 NOMAC-E2 "Batch B")

    Completed
    Has Results
    • Healthy Postmenopausal Females
    • Commercial NOMAC-E2
    • +2 more
    • (no location specified)
    Feb 7, 2022